Comments
Loading...

Fennec Pharmaceuticals

FENCNASDAQ
Logo brought to you by Benzinga Data
$5.22
-0.04-0.76%
At Close: -
$5.22
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Overweight
Highest Price Target1
$19.00
Lowest Price Target1
$11.00
Consensus Price Target1
$14.33

Fennec Pharmaceuticals (NASDAQ:FENC) Stock, Analyst Ratings, Price Targets, Forecasts

Fennec Pharmaceuticals Inc has a consensus price target of $14.33 based on the ratings of 6 analysts. The high is $19 issued by Wedbush on September 26, 2022. The low is $11 issued by Capital One on September 7, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Craig-Hallum, and Craig-Hallum on August 22, 2024, August 14, 2024, and May 15, 2024, respectively. With an average price target of $15 between HC Wainwright & Co., Craig-Hallum, and Craig-Hallum, there's an implied 187.36% upside for Fennec Pharmaceuticals Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Apr
0
0
0
0
May
0
0
0
0
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.4
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Craig-Hallum
Cantor Fitzgerald
Cantor Fitzgerald
Wedbush

1calculated from analyst ratings

Analyst Ratings for Fennec Pharmaceuticals

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Fennec Pharmaceuticals (FENC) stock?

A

The latest price target for Fennec Pharmaceuticals (NASDAQ:FENC) was reported by HC Wainwright & Co. on August 22, 2024. The analyst firm set a price target for $13.00 expecting FENC to rise to within 12 months (a possible 149.04% upside). 6 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Fennec Pharmaceuticals (FENC)?

A

The latest analyst rating for Fennec Pharmaceuticals (NASDAQ:FENC) was provided by HC Wainwright & Co., and Fennec Pharmaceuticals maintained their buy rating.

Q

When was the last upgrade for Fennec Pharmaceuticals (FENC)?

A

The last upgrade for Fennec Pharmaceuticals Inc happened on November 22, 2022 when Cantor Fitzgerald raised their price target to $12. Cantor Fitzgerald previously had a neutral for Fennec Pharmaceuticals Inc.

Q

When was the last downgrade for Fennec Pharmaceuticals (FENC)?

A

There is no last downgrade for Fennec Pharmaceuticals.

Q

When is the next analyst rating going to be posted or updated for Fennec Pharmaceuticals (FENC)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Fennec Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Fennec Pharmaceuticals was filed on August 22, 2024 so you should expect the next rating to be made available sometime around August 22, 2025.

Q

Is the Analyst Rating Fennec Pharmaceuticals (FENC) correct?

A

While ratings are subjective and will change, the latest Fennec Pharmaceuticals (FENC) rating was a maintained with a price target of $15.00 to $13.00. The current price Fennec Pharmaceuticals (FENC) is trading at is $5.22, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.